A recent study published in the Annals of Internal Medicine found that exposure to aluminum from vaccines during childhood does not increase the risk of chronic neurodevelopmental, autoimmune, atopic, or allergic disorders. The study, conducted on 1.2 million Danish children over a 24-year period, analyzed data from the Vaccine Safety Datalink and found no association between aluminum exposure and these conditions.
The researchers, led by Dr. Niklas Worm Andersson, found that aluminum salts in vaccines are not associated with an increased risk of 50 health conditions in early childhood. The study’s findings provide robust evidence supporting the safety of childhood vaccines.
Some readers had called for the study to be retracted due to perceived flaws in its methodology and findings. However, the editor-in-chief of the Annals of Internal Medicine, Dr. Christine Laine, has defended the study, stating that it is one of the strongest research studies on the topic and that it provides valuable information to help understand the safety of childhood vaccines.
The study’s authors used a dataset “much richer than those available in the U.S.” and subjected their work to rigorous peer review. While observational studies can never be definitive, Annals stands by its judgment that the study found no evidence for an association between dose of vaccine-related aluminum and chronic conditions in early childhood.
Aluminum salts have been added to vaccines since the 1930s to boost immune response. The average infant receives about 4.4 mg of aluminum during their first six months from vaccines, but they also ingest significant amounts from breast milk, formula, or soy formula.
Source: https://www.medpagetoday.com/neurology/autism/116944